Aiolos Bio, Inc., a clinical-stage biotechnology company, appointed René van der Merwe, chief medical officer, and Tapan Maniar, chief business officer. van der Merwe brings more than two decades of R&D experience, having led global development programs for multiple approved asthma biologics. She served as vice president of respiratory development at AstraZeneca’s biologics division, MedImmune, where she was clinical program lead for tezepelumab and benralizumab in asthma, COPD, and atopi...